Target intelligence / Profile preview

Natural killer cell activating receptor pathways and downstream cytotoxic effectors (NK cell activation pathways)

Target
NK cell activation pathways
Molecular classification
Receptor, Enzyme, Cytokine, Signaling protein, Cell surface protein, Other
01

Overview

Natural killer (NK) cell activating receptor pathways and downstream cytotoxic effectors represent the integrated molecular system through which NK cells identify and eliminate target cells, such as those that are virally infected or malignant. This system relies on a diverse array of activating receptors, including NKG2D, natural cytotoxicity receptors (NKp30, NKp44, NKp46), and CD16 (FcγRIIIa), which recognize stress-induced ligands or antibody-coated cells [UniProt; Vivier et al., 2011]. Upon activation, these receptors initiate signaling cascades that lead to the release of cytotoxic granules containing perforin and granzymes, which cooperatively induce apoptosis in the target cell [PubMed: 21508924]. Additionally, NK cells utilize death receptor ligands like FasL and TRAIL and secrete pro-inflammatory cytokines such as IFN-γ to enhance the immune response [Shimasaki et al., 2020]. Therapeutic modulation of these pathways is a cornerstone of modern oncology, utilizing monoclonal antibodies to drive antibody-dependent cellular cytotoxicity (ADCC) and developing next-generation CAR-NK cell therapies to harness these potent effector mechanisms against solid and hematological tumors [Nature Reviews Drug Discovery, 2020]. Safety considerations for these therapies include cytokine release syndrome and potential on-target off-tumor effects, though NK cells generally exhibit a more favorable safety profile than T-cell-based therapies [PubMed: 31092554].

Other names
NK cell activation signalingNK cell cytotoxicity machineryNK cell effector pathwaysNK cell activating receptors and effectorsNK cell activation cascadeNK cell activation signaling pathway
02

Mechanism of action

The mechanism involves the engagement of activating receptors (e.g., NKG2D, CD16) by their respective ligands, leading to the phosphorylation of ITAM or YINM motifs on adapter proteins. This triggers downstream signaling through PI3K, PLCγ, and MAPK pathways, resulting in the mobilization of the microtubule-organizing center (MTOC) and the exocytosis of cytotoxic granules containing perforin and granzymes into the immunological synapse. Additionally, NK cells can induce apoptosis via Fas/FasL and TRAIL/TRAIL-R interactions [Vivier et al., 2011; Shimasaki et al., 2020].

03

Biological functions

Immune responseApoptosisCell deathSignal transductionCytolysisCell proliferationOther
04

Disease associations

CancerInfectionAutoimmune diseaseInflammationOther
05

Safety considerations

Cytokine release syndrome (CRS)On-target off-tumor toxicityAutoimmunityGraft-versus-host disease (GvHD)Infusion-related reactionsTumor lysis syndromeNeurotoxicity
06

Interacting drugs

10 more in the full profile.

07

Biomarkers

CD56CD16 (FcγRIIIa)NKG2D (KLRK1)Granzyme B (GZMB)Perforin (PRF1)Interferon-gamma (IFN-γ)NKp46 (NCR1)NKp30 (NCR3)NKp44 (NCR2)CD107a (LAMP-1)

Beyond the preview

Go deeper on Natural killer cell activating receptor pathways and downstream cytotoxic effectors (NK cell activation pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer cell activating receptor pathways and downstream cytotoxic effectors (NK cell activation pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call